\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Horizon Europe NMBPThe European Institute of Innovation and Technology (EIT) is launching the HEI Initiative: Innovation Capacity Building for Higher Education − a new initiative to unlock the full innovation potential of higher education institutions’ (HEIs) by increasing their entrepreneurial and innovation capacity whilst integrating them into Europe’s largest innovation ecosystem.
The initiative is a joint activity of the entire EIT Community coordinated by EIT RawMaterials. The Pilot Call for Proposals invites European higher education institutions to design institution-wide action plans that will improve their entrepreneurial and innovation capacity across all institutional levels. By supporting such activities, this new EIT initiative will create systemic impact, empowering HEIs to become regional engines of innovation and foster sustainable growth and jobs across Europe.
A total of 23 pilot projects will be selected and implemented over 24 months from July 2021. Each pilot project could be awarded a maximum of EUR 1.2 million with up to EUR 400 000 for Phase 1 (July−December 2021) and up to EUR 800,000 for Phase 2 (January 2022-July 2023). Activities can focus on several themes, including:
The deadline for submitting proposals is 25 May 2021, and the selected pilot projects will be announced in June 2021. To learn more about the HEI Initiative and for the full Pilot Call for Proposals, visit the HEI Initiative website and see factsheet.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The European Commission has recently published the first amendment to the Digital Europe Main Work Programme 2025-2027, taking into account the most recent political priorities of the Commission. Among the main changes, the programme will now contribute to the landmark AI Gigafactories initiative, set to accelerate the development of cutting... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
